[HTML][HTML] Hereditary prostate cancer: genes related, target therapy and prevention
MT Vietri, G D'elia, G Caliendo, M Resse… - International journal of …, 2021 - mdpi.com
Prostate cancer (PCa) is globally the second most diagnosed cancer type and the most
common cause of cancer-related deaths in men. Family history of PCa, hereditary breast …
common cause of cancer-related deaths in men. Family history of PCa, hereditary breast …
[HTML][HTML] Cost-of-illness studies: concepts, scopes, and methods
C Jo - Clinical and molecular hepatology, 2014 - ncbi.nlm.nih.gov
Liver diseases are one of the main causes of death, and their ever-increasing prevalence is
threatening to cause significant damage both to individuals and society as a whole. This …
threatening to cause significant damage both to individuals and society as a whole. This …
[HTML][HTML] Blood-based liquid biopsies for prostate cancer: clinical opportunities and challenges
Liquid biopsy has been established as a powerful, minimally invasive, tool to detect clinically
actionable aberrations across numerous cancer types in real-time. With the development of …
actionable aberrations across numerous cancer types in real-time. With the development of …
[HTML][HTML] A survey of open questions in adaptive therapy: Bridging mathematics and clinical translation
Adaptive therapy is a dynamic cancer treatment protocol that updates (or 'adapts') treatment
decisions in anticipation of evolving tumor dynamics. This broad term encompasses many …
decisions in anticipation of evolving tumor dynamics. This broad term encompasses many …
[HTML][HTML] Clinical validation of a next-generation sequencing-based multi-cancer early detection “liquid biopsy” blood test in over 1,000 dogs using an independent …
A Flory, KM Kruglyak, JA Tynan, LM McLennan… - PLoS …, 2022 - journals.plos.org
Cancer is the leading cause of death in dogs, yet there are no established screening
paradigms for early detection. Liquid biopsy methods that interrogate cancer-derived …
paradigms for early detection. Liquid biopsy methods that interrogate cancer-derived …
[HTML][HTML] The Lancet Commission on prostate cancer: planning for the surge in cases
Executive summary Prostate cancer is the most common cancer in men in 112 countries,
and accounts for 15% of cancers. In this Commission, we report projections of prostate …
and accounts for 15% of cancers. In this Commission, we report projections of prostate …
[HTML][HTML] Quantitative and qualitative analysis of blood-based liquid biopsies to inform clinical decision-making in prostate cancer
Context Genomic stratification can impact prostate cancer (PC) care through diagnostic,
prognostic, and predictive biomarkers that aid in clinical decision-making. The temporal and …
prognostic, and predictive biomarkers that aid in clinical decision-making. The temporal and …
[HTML][HTML] Liquid biopsies beyond mutation calling: genomic and epigenomic features of cell-free DNA in cancer
AK Angeles, F Janke, S Bauer, P Christopoulos… - Cancers, 2021 - mdpi.com
Simple Summary Liquid biopsies provide a non-invasive means to diagnose and profile
tumors when tissue is not available. Sequence-based analysis of cell-free DNA (cfDNA) is …
tumors when tissue is not available. Sequence-based analysis of cell-free DNA (cfDNA) is …
[HTML][HTML] Detection of ctDNA in plasma of patients with clinically localised prostate cancer is associated with rapid disease progression
Background DNA originating from degenerate tumour cells can be detected in the circulation
in many tumour types, where it can be used as a marker of disease burden as well as to …
in many tumour types, where it can be used as a marker of disease burden as well as to …
[HTML][HTML] Validation of a liquid biopsy assay with molecular and clinical profiling of circulating tumor DNA
JD Finkle, H Boulos, TM Driessen, C Lo… - NPJ Precision …, 2021 - nature.com
Liquid biopsy is a valuable precision oncology tool that is increasingly used as a non-
invasive approach to identify biomarkers, detect resistance mutations, monitor disease …
invasive approach to identify biomarkers, detect resistance mutations, monitor disease …